PBE
Invesco Biotechnology & Genome ETF
Set alert
102.50 USD -0.96 -0.93%
102.29 Day range 104.24
73.22 52-week range 103.46
- YTD
- +24.77%
- 1 year
- +39.99%
- Open
- 103.47
- Prev close
- 103.46
- Mkt cap
- 315.42M
- Vol
- 13.14K
- Avg vol
- 30.18K
- EPS
- 3.66
- P/E
- 27.98
- Div yield
- 0.00%
More statistics
- Low
- 102.29
- High
- 104.24
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 69.17
- 200-d avg
- 67.04
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 23.60
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 69.17
- 200-day average
- 67.04
About Invesco Biotechnology & Genome ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on PBE — it syncs with the Stock Master app.